Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Martinelli

Showing results (61-70 of 658) with videos related to

Pageof 66
Sort By:
Cancer Chemotherapy and Pharmacology|September 30, 2006
cDNA microarray study to identify expression changes relevant for apoptosis in K562 cells co-treated with amifostine and imatinibMichele Bianchini, Giovanni Martinelli, Matteo Renzulli, et al.
Scientific Data|December 17, 2025
A global dataset of helium isotopic data in tectonically and hydrothermally active geological environmentsFabrizio Gherardi, Gianluca Facca, Lisa Pierotti, et al.
Lancet (London, England)|October 1, 2013
Treatment for patients with indolent and mantle cell lymphomaEmanuele Zucca, Catherine Thieblemont, Giovanni Martinelli, et al.
Hematology Reports|October 12, 2020
How we manage smoldering multiple myelomaAlessandra Romano, Claudio Cerchione, Concetta Conticello, et al.
Molecular Cancer|April 2, 2020
Linear and circular PVT1 in hematological malignancies and immune response: two faces of the same coinMartina Ghetti, Ivan Vannini, Clelia Tiziana Storlazzi, et al.
Panminerva Medica|September 21, 2020
BCMA-targeting approaches for treatment of multiple myelomaYunxin Chen, Chandramouli Nagarajan, Melinda S Tan, et al.
Journal of Hematology & Oncology|September 22, 2020
A WEE1 family business: regulation of mitosis, cancer progression, and therapeutic targetAndrea Ghelli Luserna di Rorà, Claudio Cerchione, Giovanni Martinelli, et al.
Panminerva Medica|September 21, 2020
Current and future perspectives of maintenance therapy in multiple myelomaChandramouli Nagarajan, Melinda S Tan, Yunxin Chen, et al.
Journal of Cellular Biochemistry|December 17, 2009
RAD 001 (everolimus) prevents mTOR and Akt late re-activation in response to imatinib in chronic myeloid leukemiaManuela Mancini, Sara Petta, Giovanni Martinelli, et al.
Molecules (Basel, Switzerland)|February 11, 2023
Targeting Proliferation Signals and the Cell Cycle Machinery in Acute Leukemias: Novel Molecules on the HorizonAndrea Ghelli Luserna di Rorà, Mouna Jandoubi, Giovanni Martinelli, et al.
Pageof 66

Showing results (61-70 of 658) with videos related to

Sort By:
Pageof 66
Cancer Chemotherapy and Pharmacology|September 30, 2006
cDNA microarray study to identify expression changes relevant for apoptosis in K562 cells co-treated with amifostine and imatinibMichele Bianchini, Giovanni Martinelli, Matteo Renzulli, et al.
Scientific Data|December 17, 2025
A global dataset of helium isotopic data in tectonically and hydrothermally active geological environmentsFabrizio Gherardi, Gianluca Facca, Lisa Pierotti, et al.
Lancet (London, England)|October 1, 2013
Treatment for patients with indolent and mantle cell lymphomaEmanuele Zucca, Catherine Thieblemont, Giovanni Martinelli, et al.
Hematology Reports|October 12, 2020
How we manage smoldering multiple myelomaAlessandra Romano, Claudio Cerchione, Concetta Conticello, et al.
Molecular Cancer|April 2, 2020
Linear and circular PVT1 in hematological malignancies and immune response: two faces of the same coinMartina Ghetti, Ivan Vannini, Clelia Tiziana Storlazzi, et al.
Panminerva Medica|September 21, 2020
BCMA-targeting approaches for treatment of multiple myelomaYunxin Chen, Chandramouli Nagarajan, Melinda S Tan, et al.
Journal of Hematology & Oncology|September 22, 2020
A WEE1 family business: regulation of mitosis, cancer progression, and therapeutic targetAndrea Ghelli Luserna di Rorà, Claudio Cerchione, Giovanni Martinelli, et al.
Panminerva Medica|September 21, 2020
Current and future perspectives of maintenance therapy in multiple myelomaChandramouli Nagarajan, Melinda S Tan, Yunxin Chen, et al.
Journal of Cellular Biochemistry|December 17, 2009
RAD 001 (everolimus) prevents mTOR and Akt late re-activation in response to imatinib in chronic myeloid leukemiaManuela Mancini, Sara Petta, Giovanni Martinelli, et al.
Molecules (Basel, Switzerland)|February 11, 2023
Targeting Proliferation Signals and the Cell Cycle Machinery in Acute Leukemias: Novel Molecules on the HorizonAndrea Ghelli Luserna di Rorà, Mouna Jandoubi, Giovanni Martinelli, et al.
Pageof 66